JFL Life

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE0LA901015
NSEID: JFLLIFE
BSEID:
View on NSE

INR

10.55

-0.4 (-3.65%)

BSENSE

Feb 04

BSE+NSE Vol: 24000

{
  "main_header": {
    "sid": 1003691,
    "name": "JFL Life",
    "stock_name": "JFL Life",
    "full_name": "JFL Life Sciences Ltd",
    "name_url": "stocks-analysis/jfl-life",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "10.55",
    "chg": -0.4,
    "chgp": "-3.65%",
    "dir": -1,
    "prev_price": "10.95",
    "mcapval": "36.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "JFLLIFE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0LA901015",
    "curr_date": "Feb 04",
    "curr_time": "",
    "bse_nse_vol": 24000,
    "exc_status": "Active",
    "traded_date": "Feb 04, 2026",
    "traded_date_str": "2026 02 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jfl-life-1003691-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "JFL Life Sciences Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jfl-life-sciences-ltd-plunges-to-lower-circuit-amid-heavy-selling-pressure-3820549",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/JFLLifeSciences_stocks_hitting_lower_circuit_3820549.png",
        "date": "2026-02-04 11:00:09",
        "description": "Shares of JFL Life Sciences Ltd plunged to their lower circuit limit on 4 Feb 2026, closing at ₹10.55, down 3.65% from the previous close. The stock witnessed intense selling pressure, with volumes falling sharply and investor participation dwindling, signalling a wave of panic selling in this micro-cap pharmaceutical player."
      },
      {
        "title": "JFL Life Sciences Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jfl-life-sciences-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3816156",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/JFLLifeSciences_stocks_hitting_lower_circuit_3816156.png",
        "date": "2026-02-02 10:00:22",
        "description": "Shares of JFL Life Sciences Ltd plunged to their lower circuit limit on 2 Feb 2026, closing at ₹10.45, marking a maximum daily loss of 5.0%. The stock faced intense selling pressure, with panic selling dominating trade and leaving significant unfilled supply at the close. This sharp decline comes amid deteriorating investor sentiment and a weak sectoral backdrop."
      },
      {
        "title": "JFL Life Sciences Gains 8.96%: 3 Key Factors Driving the Week’s Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jfl-life-sciences-gains-896-3-key-factors-driving-the-weeks-rally-3812676",
        "imagepath": "",
        "date": "2026-01-31 11:01:23",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jan 27:</strong> Stock opens at Rs.10.00, dips slightly by 0.50% amid flat market sentiment</p>\n                    <p><strong>Jan 28:</strong> Stock holds steady at Rs.10.00 as Sensex gains 1.12%</p>\n                    <p><strong>Jan 29:</strong> Quarterly results announced; stock surges 4.50% to Rs.10.45 on strong revenue growth</p>\n                    <p><strong>Jan 30:</strong> Stock hits upper circuit at Rs.10.95, up 4.78%, driven by robust buying pressure</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.10.05</div></div>\n                    <div cl..."
      },
      {
        "title": "JFL Life Sciences Ltd Surges to Upper Circuit Amid Robust Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jfl-life-sciences-ltd-surges-to-upper-circuit-amid-robust-buying-pressure-3810950",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JFLLifeSciences_stocks_hitting_upper_circuit_3810950.png",
        "date": "2026-01-30 10:00:43",
        "description": "JFL Life Sciences Ltd surged to hit its upper circuit price limit on 30 Jan 2026, registering a maximum daily gain of 4.78% amid robust buying interest and heightened investor participation. The stock closed at ₹10.95, marking a notable outperformance against its sector and the broader market indices."
      },
      {
        "title": "JFL Life Sciences Ltd Reports Strong Quarterly Growth Amid Challenging Market Conditions",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jfl-life-sciences-ltd-reports-strong-quarterly-growth-amid-challenging-market-conditions-3810535",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JFLLifeSciences_fintrenddot_3810535.png",
        "date": "2026-01-30 08:00:33",
        "description": "JFL Life Sciences Ltd has demonstrated a marked turnaround in its financial performance for the quarter ended December 2025, posting robust revenue growth and margin expansion that contrasts sharply with its recent historical trends. Despite persistent headwinds in the broader market and a challenging sector environment, the pharmaceutical and biotechnology company has improved its financial trend from flat to positive, signalling potential stabilisation and renewed investor interest."
      },
      {
        "title": "Are JFL Life Sciences Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-jfl-life-sciences-ltd-latest-results-good-or-bad-3810128",
        "imagepath": "",
        "date": "2026-01-29 19:25:31",
        "description": "JFL Life Sciences Ltd's latest financial results reveal a company experiencing significant volatility in its performance. In the quarter ended September 2025, net sales surged to ₹29.91 crores, reflecting a substantial sequential increase of 158.07%. However, this figure represents a decline of 24.30% compared to the same quarter last year, highlighting the inconsistent nature of the company's revenue streams. The operating margin contracted to 9.76%, down from 16.65% in the previous quarter, indicating potential challenges in pricing power or product mix despite higher revenues.\n\nThe net profit for the same quarter was reported at ₹1.97 crores, which is a 162.67% increase from the previous quarter, yet it remains 35.86% lower than the prior year's figure. This suggests that while there was a short-term gain, the overall trend points to underlying issues in sustaining profitability.\n\nIn the subsequent quart..."
      },
      {
        "title": "JFL Life Sciences Q2 FY26: Revenue Surge Masks Underlying Volatility Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/jfl-life-sciences-q2-fy26-revenue-surge-masks-underlying-volatility-concerns-3810020",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JFLLifeSciences_quaterlyResult_3810020.png",
        "date": "2026-01-29 18:03:29",
        "description": "JFL Life Sciences Ltd., a micro-cap pharmaceutical manufacturer with a market capitalisation of ₹33.00 crores, posted net profit of ₹1.97 crores in Q2 FY26, marking a sequential surge of 162.67% quarter-on-quarter but declining 35.86% year-on-year. The stock, trading at ₹10.45 as of January 29, 2026, gained 4.50% in the latest session but remains under severe pressure, having plunged 53.96% over the past year and trading near its 52-week low of ₹10.00."
      },
      {
        "title": "JFL Life Sciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jfl-life-sciences-ltd-is-rated-sell-3799790",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JFLLifeSciences_mojoScore_3799790.png",
        "date": "2026-01-22 10:10:58",
        "description": "JFL Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "JFL Life Sciences Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jfl-life-sciences-ltd-plunges-to-lower-circuit-amid-heavy-selling-pressure-3798069",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JFLLifeSciences_stocks_hitting_lower_circuit_3798069.png",
        "date": "2026-01-21 10:00:33",
        "description": "JFL Life Sciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, plunged to its lower circuit price limit on 21 Jan 2026, closing at a new 52-week and all-time low of ₹10.1. The stock witnessed intense selling pressure, resulting in a maximum daily loss of 4.72%, significantly underperforming its sector and broader market benchmarks."
      }
    ],
    "total": 132,
    "sid": "1003691",
    "stock_news_url": "https://www.marketsmojo.com/news/jfl-life-sciences-1003691"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "JFL Life Sciences Ltd has declared <strong>2%</strong> dividend, ex-date: 13 Sep 24",
          "dt": "2024-09-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "JFL Life Sciences Ltd has announced <strong>2:1</strong> bonus issue, ex-date: 24 Sep 24",
          "dt": "2024-09-24",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

JFL Life Sciences Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure

2026-02-04 11:00:09

Shares of JFL Life Sciences Ltd plunged to their lower circuit limit on 4 Feb 2026, closing at ₹10.55, down 3.65% from the previous close. The stock witnessed intense selling pressure, with volumes falling sharply and investor participation dwindling, signalling a wave of panic selling in this micro-cap pharmaceutical player.

Read full news article

JFL Life Sciences Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-02-02 10:00:22

Shares of JFL Life Sciences Ltd plunged to their lower circuit limit on 2 Feb 2026, closing at ₹10.45, marking a maximum daily loss of 5.0%. The stock faced intense selling pressure, with panic selling dominating trade and leaving significant unfilled supply at the close. This sharp decline comes amid deteriorating investor sentiment and a weak sectoral backdrop.

Read full news article

JFL Life Sciences Gains 8.96%: 3 Key Factors Driving the Week’s Rally

2026-01-31 11:01:23

Key Events This Week

Jan 27: Stock opens at Rs.10.00, dips slightly by 0.50% amid flat market sentiment

Jan 28: Stock holds steady at Rs.10.00 as Sensex gains 1.12%

Jan 29: Quarterly results announced; stock surges 4.50% to Rs.10.45 on strong revenue growth

Jan 30: Stock hits upper circuit at Rs.10.95, up 4.78%, driven by robust buying pressure

Week Open

Rs.10.05

Read full news article

JFL Life Sciences Ltd Surges to Upper Circuit Amid Robust Buying Pressure

2026-01-30 10:00:43

JFL Life Sciences Ltd surged to hit its upper circuit price limit on 30 Jan 2026, registering a maximum daily gain of 4.78% amid robust buying interest and heightened investor participation. The stock closed at ₹10.95, marking a notable outperformance against its sector and the broader market indices.

Read full news article

JFL Life Sciences Ltd Reports Strong Quarterly Growth Amid Challenging Market Conditions

2026-01-30 08:00:33

JFL Life Sciences Ltd has demonstrated a marked turnaround in its financial performance for the quarter ended December 2025, posting robust revenue growth and margin expansion that contrasts sharply with its recent historical trends. Despite persistent headwinds in the broader market and a challenging sector environment, the pharmaceutical and biotechnology company has improved its financial trend from flat to positive, signalling potential stabilisation and renewed investor interest.

Read full news article

Are JFL Life Sciences Ltd latest results good or bad?

2026-01-29 19:25:31

JFL Life Sciences Ltd's latest financial results reveal a company experiencing significant volatility in its performance. In the quarter ended September 2025, net sales surged to ₹29.91 crores, reflecting a substantial sequential increase of 158.07%. However, this figure represents a decline of 24.30% compared to the same quarter last year, highlighting the inconsistent nature of the company's revenue streams. The operating margin contracted to 9.76%, down from 16.65% in the previous quarter, indicating potential challenges in pricing power or product mix despite higher revenues. The net profit for the same quarter was reported at ₹1.97 crores, which is a 162.67% increase from the previous quarter, yet it remains 35.86% lower than the prior year's figure. This suggests that while there was a short-term gain, the overall trend points to underlying issues in sustaining profitability. In the subsequent quart...

Read full news article

JFL Life Sciences Q2 FY26: Revenue Surge Masks Underlying Volatility Concerns

2026-01-29 18:03:29

JFL Life Sciences Ltd., a micro-cap pharmaceutical manufacturer with a market capitalisation of ₹33.00 crores, posted net profit of ₹1.97 crores in Q2 FY26, marking a sequential surge of 162.67% quarter-on-quarter but declining 35.86% year-on-year. The stock, trading at ₹10.45 as of January 29, 2026, gained 4.50% in the latest session but remains under severe pressure, having plunged 53.96% over the past year and trading near its 52-week low of ₹10.00.

Read full news article

JFL Life Sciences Ltd is Rated Sell

2026-01-22 10:10:58

JFL Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

JFL Life Sciences Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure

2026-01-21 10:00:33

JFL Life Sciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, plunged to its lower circuit price limit on 21 Jan 2026, closing at a new 52-week and all-time low of ₹10.1. The stock witnessed intense selling pressure, resulting in a maximum daily loss of 4.72%, significantly underperforming its sector and broader market benchmarks.